1. Home
  2. PCF vs ASMB Comparison

PCF vs ASMB Comparison

Compare PCF & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCF
  • ASMB
  • Stock Information
  • Founded
  • PCF 1987
  • ASMB 2005
  • Country
  • PCF United States
  • ASMB United States
  • Employees
  • PCF N/A
  • ASMB N/A
  • Industry
  • PCF Trusts Except Educational Religious and Charitable
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCF Finance
  • ASMB Health Care
  • Exchange
  • PCF Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • PCF 118.8M
  • ASMB 130.2M
  • IPO Year
  • PCF N/A
  • ASMB 2010
  • Fundamental
  • Price
  • PCF $6.34
  • ASMB $17.47
  • Analyst Decision
  • PCF
  • ASMB Strong Buy
  • Analyst Count
  • PCF 0
  • ASMB 3
  • Target Price
  • PCF N/A
  • ASMB $33.00
  • AVG Volume (30 Days)
  • PCF 74.8K
  • ASMB 29.9K
  • Earning Date
  • PCF 01-01-0001
  • ASMB 08-07-2025
  • Dividend Yield
  • PCF 10.90%
  • ASMB N/A
  • EPS Growth
  • PCF N/A
  • ASMB N/A
  • EPS
  • PCF N/A
  • ASMB N/A
  • Revenue
  • PCF N/A
  • ASMB $32,154,000.00
  • Revenue This Year
  • PCF N/A
  • ASMB $0.04
  • Revenue Next Year
  • PCF N/A
  • ASMB N/A
  • P/E Ratio
  • PCF N/A
  • ASMB N/A
  • Revenue Growth
  • PCF N/A
  • ASMB 148.33
  • 52 Week Low
  • PCF $5.71
  • ASMB $7.75
  • 52 Week High
  • PCF $6.96
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • PCF 53.42
  • ASMB 70.64
  • Support Level
  • PCF $6.34
  • ASMB $16.50
  • Resistance Level
  • PCF $6.38
  • ASMB $17.94
  • Average True Range (ATR)
  • PCF 0.04
  • ASMB 0.78
  • MACD
  • PCF 0.00
  • ASMB -0.06
  • Stochastic Oscillator
  • PCF 60.00
  • ASMB 85.83

About PCF High Income Securities Fund

High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: